Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 305

The DOI matches its Crossref record.

Green Chemistry in the Pharmaceutical Industry

·2010·Wiley eBooks

Abstract

INTRODUCTION TO GREEN CHEMISTRY, ORGANIC SYNTHESIS ANDPHARMACEUTICALS The Development of Organic Synthesis The Environmental Factor The Role of Catalysis Green Chemistry: Benign by Design Ibuprofen Manufacture The Question of Solvents: Alternative Reaction Media Biocatalysis: Green Chemistry Meets White Biotechnology Conclusions and Prospects GREEN CHEMISTRY METRICS Introduction Measuring Resource Usage Life Cycle Assessment (LCA) Measuring Chemistry and Process Efficiency Measuring Process Parameters and Emissions Real Time Analysis Operational Efficiency Measuring Energy Measuring the Toxicity of All the Substrates Measuring Degradation Potential Measuring the Inherent Safety of Lack of Inherent Safety Conclusions SOLVENT USE AND WASTE ISSUES Introduction to Solvent Use and Waste Issues Solvent and Process Greenness Scoring and Selection Tools Waste Minimization and Solvent Recovery ENVIRONMENTAL AND REGULATORY ASPECTS Historical Perspective Pharmaceuticals in the Environment Environmental Regulations A Look to the Future SYNTHESIS OF SITAGLIPTIN, THE ACTIVE INGREDIENT IN JANUVIA ANDJANUMET Introduction First-Generation Route Sitagliptin through Diastereoselective Hydrogenation of an Enamine.The PGA Enamine-Ester Route The Triazole Fragment Direct Preparation of Beta-Keto Amides Second-Generation Chiral Auxiliary Route. The PGA Enamine-AmideRoute Prufication and Isolation of Sitagliptin (PharmaceuticalForm) The Final Manufacturing Route THE DEVELOPMENT OF SHORT, EFFICIENT, ECONOMIC, AND SUSTAINABLECHEMOENZYMATIC PROCESSES FOR STATIN SIDE CHAINS Introduction: Biocatalysis The Relevance of Statins Biocatalytic Routes to Statin Side Chains 2-Deoxy-D-Ribose 5-Phosphate Aldolase (DERA)-Based Routes to StatinIntermediates Conclusions THE TAXOL STORY-DEVELOPMENT OF A GREEN SYNTHESIS VIA PLANT CELLFERMENTATION Introduction Discovery and Early Development From Extraction of Taxol from Pacific Yew Tree Bark toSemi-Synthetic Taxol Taxol from Plant Cell Fermentation Comparison of Semi-Synthetic versus PCF Taxol Processes: TheEnvironmental Impact Comparison of Semi-Synthetic versus PCF Taxol: Green ChemistryPrinciples Final Words THE DEVELOPMENT OF A GREEN, ENERGY EFFICIENT, CHEMOENZYMATICMANUFACTURING PROCESS OF PREGABALIN Introduction Process Routes to Pregabalin Biocatalytic Route to Pregabalin Green Chemistry Considerations Conclusions GREEN PROCESSES FOR PEPTIDE MIMETIC DIABETIC DRUGS Introduction Green Chemistry Considerations in Peptide-like APImanufacture Purification Process to Manufacture Amorphous API Preparation of Unnatural Amino Acids Summary THE DEVELOPMENT OF AN ENVIRONMENTALLY SUSTAINABLE PROCESS FORRADAFAXINE Introduction Chemistry Process and the Dynamic Kinetic Resolution (DKR) Multicolumn Chromatography ? Development of Route 4 Environmental Assessment Summary CONTINUOUS PROCESSING IN THE PHARMACEUTICAL INDUSTRY Introduction Continuous Production of a Key Intermediate for Atorvastatin Continuous Process to Prepare Celecoxib Continuous Oxidation of Alcohols to Aldehydes Continuous Production of Bromonitromethane Continuous Production and Use of Diazomehtane A Snapshot of Some Further Continuous Processes Used in thePreparation of Pharmaceutical Agents Conclusions PREPARATIVE AND INDUSTRIAL SCALE CHROMATOGRAPHY: GREEN ANDINTEGRATED PROCESSES Introduction Basic Principles of Chromatography Process Optimization to Reduce Eluent Consumption Use of a Green Solvent: Supercritical Carbon Dioxide Solvent Recycling Technologies Application Examples Conclusion: An Environmentally Friendly Solution for EachSeparation DYNAMIC RESOLUTION OF CHIRAL AMINE PHARMACEUTICALS: TURNING WASTEISOMERS INTO USEFUL PRODUCT Background Integration of Chiral Amine Resolution and Racemization Case Studies Conclusions GREEN TECHNOLOGIES IN THE GENERIC PHARMACEUTICAL INDUSTRY Introduction 'Waste': Definition and Remedy Amidation Synthesis of Galanthamine Synthesis of Solefinacin Synthesis of Levetiracetam Synthesis of a Finasteride Intermediate Bromination Sulfoxidation in the Synthesis of Rabeprazole Conclusions ENVIRONMENTAL CONSIDERATIONS IN BIOLOGICS MANUFACTURE Introduction Therapeutic Biologics Environmental Impact Considerations Overall Comparison Environmental Indices for Therapeutic Protein Manufacture Technologies with Potential Environmental Impact Single-Use Biologics Manufacture Summary FUTURE TRENDS FOR GREEN CHEMISTRY IN THE PHARMACEUTICALINDUSTRY Introduction Waste Minimization in Drug Discovery Greener Synthetic Methods in Primary Manufacturing Alternative Solvents in the Pharmaceutical Industry Green Chemistry in Secondary Pharmaceutical Operations Global Cooperation in Green Chemistry Conclusions

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/9783527629688

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 305

Metadata

Venue
Wiley eBooks
Publisher
Wiley
Published
2010-03-10
OpenAlex
W639790231
Cited by
305
References
0
FWCI
30.13
Type
book
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Green Chemistry in the Pharmaceutical Industry. https://app.cochat.ai/papers/10.1002/9783527629688
The paper
Green Chemistry in the Pharmaceutical Industry. (2010). Wiley eBooks. https://doi.org/10.1002/9783527629688

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.